These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 1708166

  • 1. Oligopeptide induction of a secondary cytotoxic T-cell response to Epstein-Barr virus in vitro.
    Schmidt C, Burrows SR, Moss DJ, Sculley TB, Misko IS.
    Scand J Immunol; 1991 Apr; 33(4):411-20. PubMed ID: 1708166
    [Abstract] [Full Text] [Related]

  • 2. Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component.
    Misko IS, Sculley TB, Schmidt C, Moss DJ, Soszynski T, Burman K.
    Cell Immunol; 1991 Feb; 132(2):295-307. PubMed ID: 1846323
    [Abstract] [Full Text] [Related]

  • 3. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ.
    J Exp Med; 1995 Jun 01; 181(6):2221-8. PubMed ID: 7539044
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3.
    Misko IS, Schmidt C, Moss DJ, Burrows SR, Sculley TB.
    J Gen Virol; 1991 Feb 01; 72 ( Pt 2)():405-9. PubMed ID: 1704413
    [Abstract] [Full Text] [Related]

  • 5. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4.
    Levitsky V, Zhang QJ, Levitskaya J, Masucci MG.
    J Exp Med; 1996 Mar 01; 183(3):915-26. PubMed ID: 8642295
    [Abstract] [Full Text] [Related]

  • 6. EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2.
    Khanna R, Burrows SR, Suhrbier A, Jacob CA, Griffin H, Misko IS, Sculley TB, Rowe M, Rickinson AB, Moss DJ.
    J Immunol; 1993 Jun 01; 150(11):5154-62. PubMed ID: 7684421
    [Abstract] [Full Text] [Related]

  • 7. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.
    Enssle KH, Fleischer B.
    Clin Exp Immunol; 1990 Mar 01; 79(3):409-15. PubMed ID: 1690617
    [Abstract] [Full Text] [Related]

  • 8. Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells.
    Khanna R, Jacob CA, Burrows SR, Kurilla MG, Kieff E, Misko IS, Sculley TB, Moss DJ.
    Immunology; 1991 Nov 01; 74(3):504-10. PubMed ID: 1722774
    [Abstract] [Full Text] [Related]

  • 9. Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides.
    Reali E, Guerrini R, Giori B, Borghi M, Marastoni M, Tomatis R, Traniello S, Masucci MG, Gavioli R.
    Clin Exp Immunol; 1996 Aug 01; 105(2):369-75. PubMed ID: 8706347
    [Abstract] [Full Text] [Related]

  • 10. A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro.
    Morgan SM, Wilkinson GW, Floettmann E, Blake N, Rickinson AB.
    J Virol; 1996 Apr 01; 70(4):2394-402. PubMed ID: 8642667
    [Abstract] [Full Text] [Related]

  • 11. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A, Buhmann R, Straka C, Emmerich B, Hallek M.
    Bone Marrow Transplant; 1998 May 01; 21(9):909-16. PubMed ID: 9613783
    [Abstract] [Full Text] [Related]

  • 12. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen.
    Hank JA, Sondel PM.
    Hum Immunol; 1984 Apr 01; 9(4):211-9. PubMed ID: 6201468
    [Abstract] [Full Text] [Related]

  • 13. Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies.
    Schmidt C, Burrows SR, Sculley TB, Moss DJ, Misko IS.
    Proc Natl Acad Sci U S A; 1991 Nov 01; 88(21):9478-82. PubMed ID: 1719531
    [Abstract] [Full Text] [Related]

  • 14. Correlation between CD8 dependency and determinant density using peptide-induced, Ld-restricted cytotoxic T lymphocytes.
    Alexander MA, Damico CA, Wieties KM, Hansen TH, Connolly JM.
    J Exp Med; 1991 Apr 01; 173(4):849-58. PubMed ID: 1901079
    [Abstract] [Full Text] [Related]

  • 15. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
    Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ.
    J Exp Med; 1992 Jul 01; 176(1):169-76. PubMed ID: 1377222
    [Abstract] [Full Text] [Related]

  • 16. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.
    Brooks JM, Murray RJ, Thomas WA, Kurilla MG, Rickinson AB.
    J Exp Med; 1993 Sep 01; 178(3):879-87. PubMed ID: 7688791
    [Abstract] [Full Text] [Related]

  • 17. Use of Epstein-Barr virus-transformed, autologous B-lymphoblastoid cells as antigen-presenting cells for establishment and maintenance of dengue virus-specific, human cytotoxic T lymphocyte clones.
    Livingston PG, Kurane I, Ennis FA.
    J Virol Methods; 1997 Aug 01; 67(1):77-84. PubMed ID: 9274820
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human cytotoxic T lymphocytes. III. Large numbers of peripheral blood T cells clonally develop into allorestricted anti-viral cytotoxic T cell populations in vitro.
    Kabelitz D, Herzog WR, Heeg K, Wagner H, Reimann J.
    J Mol Cell Immunol; 1987 Aug 01; 3(1):49-60. PubMed ID: 2855406
    [Abstract] [Full Text] [Related]

  • 20. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF, Ladanyi M, Louie DC, Fernandez JM, Papadopoulos EB, O'Reilly RJ.
    J Exp Med; 1996 Mar 01; 183(3):1215-28. PubMed ID: 8642263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.